X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.newswire.ca/news-releases/erleada-r-apalutamide-240-mg-approved-as-the-only-androgen-receptor-inhibitor-with-a-once-daily-single-tablet-option-in-canada-824240082.html
https://www.prnewswire.com/news-releases/erleada-apalutamide-first-and-only-next-generation-androgen-receptor-inhibitor-with-once-daily-single-tablet-option-now-available-in-the-us-301787489.html
https://nation.africa/kenya/news/fda-approves-injectable-drug-for-resistant-hiv-4073822
https://endpts.com/jj-takes-aurobindo-to-court-over-potential-erleada-generic/
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-apalutamide-tablets-1649311994.pdf
https://johnsonandjohnson.gcs-web.com/static-files/28d869b1-8230-473a-a011-e40c8bbcac15
https://www.pharmaceutical-technology.com/news/jj-split-consumer-health-pharmaceutical/
https://www.pharmatimes.com/news/nice_changes_its_mind_on_janssens_erleada_1376372
https://www.raps.org/news-and-articles/news-articles/2021/8/fda-finalizes-guidance-on-metastasis-free-survival
http://www.pharmatimes.com/news/janssens_erleada_maintains_quality_of_life_for_prostate_cancer_patients_1370808
http://www.pharmafile.com/news/578303/nice-rejects-janssens-prostate-cancer-drug-erleada
https://www.businesswire.com/news/home/20210209005604/en/Janssen-Presents-Results-from-Phase-3-ACIS-Study-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer-Treated-with-Apalutamide%E2%96%BC-and-Abiraterone-Acetate-Combination
https://en.prnasia.com/releases/global/kangpu-to-present-two-posters-at-the-2020-american-association-for-cancer-research-aacr-annual-meeting-282967.shtml
https://www.prnewswire.com/news-releases/janssen-highlights-innovative-oncology-portfolio-and-pipeline-of-oral-biologic-and-cell-therapies-through-asco20-virtual-scientific-program-301067691.html
https://www.fiercepharma.com/pharma/asco-j-j-s-erleada-extends-lives-by-14-months-nonmetastatic-prostate-cancer
https://www.prnewswire.com/news-releases/erleada-apalutamide-significantly-improved-overall-survival-in-patients-with-non-metastatic-castration-resistant-prostate-cancer-301058911.html
https://www.biospectrumasia.com/news/30/15422/who-to-accelerate-research-and-innovation-for-new-coronavirus.html
https://www.fiercepharma.com/marketing/bayer-s-nubeqa-gets-better-chance-at-challenging-pfizer-and-j-j-prostate-cancer-key
http://www.pharmafile.com/news/539813/janssens-erleada-expanded-europe-cover-metastatic-hormone-sensitive-prostate-cancer
https://www.businesswire.com/news/home/20200129005336/en/Janssen-Announces-European-Commission-Approval-Expanded-Erleada%C2%AE%E2%96%BC/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.fiercepharma.com/pharma/esmo-j-j-s-erleada-misses-survival-mark-but-execs-see-reason-to-cheer
https://www.biopharmadive.com/news/johnson-erleada-approval-prostate-cancer-pfizer-xtandi/563198/
https://www.raps.org/news-and-articles/news-articles/2019/9/fda-collaborates-with-health-canada-australia-to
https://www.fiercepharma.com/pharma/asco-pfizer-astellas-xtandi-racks-up-more-data-for-new-prostate-cancer-use
https://www.fiercepharma.com/pharma/asco-j-j-pads-case-for-new-erleada-use-prostate-cancer-survival-data
https://www.fiercepharma.com/pharma/asco-2019-what-to-watch-for-including-keytruda-lynparza-seagen-and-more
https://www.fiercepharma.com/marketing/j-j-eyes-prostate-cancer-boost-as-fda-accepts-erleada-for-real-time-review
https://endpts.com/fda-tags-bayers-prostate-cancer-drug-for-priority-review-as-drugmaker-gears-up-against-rivals/
https://www.prnewswire.com/news-releases/janssen-submits-application-to-us-fda-seeking-approval-of-erleada-apalutamide-for-patients-with-metastatic-castration-sensitive-prostate-cancer-300840126.html
https://www.ema.europa.eu/documents/product-information/erleada-epar-product-information_en.pdf
http://www.evaluate.com/vantage/articles/news/trial-results/asco-gu-bayer-and-orion-have-their-work-cut-out-darolutamide?mkt_tok=eyJpIjoiT0RKa04yTTVaV1ZoWWpZeCIsInQiOiJ4bnU5VmdUSnBIbWhEdUQ1ZDd4TmQxNTNpY1lLY0taSndKSUpWU0wzNE9memF2TktEM2tSeEhnVVR0dXRIdko1ZGxTQ1hJRHh1YXNCNzA1eHpWUXpuVzZYZWRNVk1CdThEVmh5dGJheU1TZEpxeWhqNnlUb25DaDVkMWM5Y0hXdSJ9
https://www.biopharmadive.com/news/new-prostate-cancer-data-puts-bayer-drug-in-line-with-pfizer-jj-rivals/548570/
https://www.reuters.com/article/us-bayer-orion-prostate-cancer/bayer-stresses-drugs-tolerability-in-bid-for-prostate-cancer-market-idUSKCN1Q32YV
https://www.fiercepharma.com/pharma/j-j-s-erleada-trial-stops-early-good-news-setting-up-case-for-new-prostate-cancer-nod
https://www.pharmaceutical-technology.com/news/us-idmc-recommends-janssen-erleada-mcspc/
https://endpts.com/jj-scores-another-phiii-win-for-erleada-as-it-continues-to-build-a-blockbuster-franchise/
https://www.fiercepharma.com/marketing/pfizer-s-xtandi-blows-by-erleada-hot-start-new-prostate-cancer-field
http://www.pharmatimes.com/news/eu_licence_granted_for_erleada_in_prostate_cancer_1275526
https://endpts.com/jj-fronts-new-cancer-drug-pact-with-500m-in-cash-for-argenxs-aml-antibody/
https://www.businesswire.com/news/home/20181116005228/en/Janssen-receives-positive-CHMP-opinion-ERLEADA%E2%84%A2-apalutamide
https://www.raps.org/news-and-articles/news-articles/2018/11/fda-drafts-guidance-on-using-metastasis-free-survi?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2013%20November
https://www.pharmacompass.com/pdf/news/anvisa-approved-janssen-cilag-farmacêuticas-erleada-for-prostate-cancer-1540288421.pdf
Market Place
Share 